Clinical Trials Directory

Trials / Conditions / Neuroblastoma (NB)

Neuroblastoma (NB)

9 registered clinical trials studyying Neuroblastoma (NB) — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPhase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in
NCT07318831
Tianjin Medical University Cancer Institute and HospitalPhase 2
RecruitingChemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapse
NCT07375563
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 3
Not Yet RecruitingValidation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
NCT06873672
RenJi Hospital—
RecruitingSafety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round C
NCT06836505
Sun Yat-Sen University Cancer CenterPhase 1 / Phase 2
Enrolling By InvitationRisk Model for Metastasis Detection of Neuroblastoma
NCT06703944
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine—
RecruitingSafety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
NCT06674265
Marzieh EbrahimiPhase 1
RecruitingClinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the
NCT07064746
Nanjing First Hospital, Nanjing Medical University—
Active Not RecruitingStudy of Chemoimmunotherapy for High-Risk Neuroblastoma
NCT03189706
Memorial Sloan Kettering Cancer CenterEARLY_Phase 1
No Longer AvailableFecal Microbiota Transplant for Neuroblastoma in a Single Patient
NCT07223606
ProgenaBiome—